TickerFactsScreenerDevelopers

Spero Therapeutics, Inc. (SPRO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $256.0K2015: $5.69M2016: $10.31M2017: $87.29M2018: $34.08M2019: $29.73M2020: $85.21M2021: $112.58M2022: $109.11M2023: $76.33M2024: $52.89M2025: $40.27M$40.27M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$40.27M-23.9%
2024$52.89M-30.7%
2023$76.33M-30.0%
2022$109.11M-3.1%
2021$112.58M+32.1%
2020$85.21M+186.6%
2019$29.73M-12.8%
2018$34.08M-61.0%
2017$87.29M+746.2%
2016$10.31M+81.3%
2015$5.69M+2123.0%
2014$256.0K—